Literature DB >> 17082597

TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.

Grit-Carsta Bulwin1, Thomas Heinemann, Volker Bugge, Michael Winter, Anke Lohan, Mirko Schlawinsky, Anke Schulze, Stephanie Wälter, Robert Sabat, Ralf Schülein, Burkhard Wiesner, Rüdiger W Veh, Jürgen Löhler, Richard S Blumberg, Hans-Dieter Volk, Nalân Utku.   

Abstract

Ab targeting of TIRC7 has been shown previously to inhibit T cell proliferation and Th1 lymphocyte-associated cytokine production. In this study, we demonstrate that Ab targeting of TIRC7 induces early cell surface expression of CTLA-4. The majority of stimulated CD4+ and CD8+ human T cells coexpress CTLA-4 and TIRC7. Similar to CTLA-4, TIRC7 rapidly accumulates at the site of Ag adhesion upon T cell activation. TIRC7 seems to colocalize with CTLA-4 in human T cells, and both molecules are associated with clathrin-coated vesicles, indicating they share intracellular transport systems. Moreover, Ab targeting of TIRC7 results in an early activation of CTLA-4 transcription. The inhibition of cell proliferation mediated by TIRC7 is dependent on CTLA-4 expression because the TIRC7-mediated inhibitory effects on cell proliferation and cytokine expression are abolished by Ab blockade of CTLA-4. Splenocytes obtained from CTLA-4-deficient mice are not responsive to TIRC7 Ab targeting. Thus, TIRC7 acts as an upstream regulatory molecule of CTLA-4 expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082597     DOI: 10.4049/jimmunol.177.10.6833

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.

Authors:  Feng Zhu; Jianlin Qiao; Xiao-min Zhong; Qing-yun Wu; Wei Chen; Yao Yao; Ming-shan Niu; Chun-ling Fu; Ling-yu Zeng; Zhen-yu Li; Kai-lin Xu
Journal:  Med Oncol       Date:  2015-06-07       Impact factor: 3.064

Review 2.  Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome.

Authors:  Andrew J Ramsay; Alejandra Martínez-Trillos; Pedro Jares; David Rodríguez; Agnieszka Kwarciak; Víctor Quesada
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

3.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Authors:  Víctor Quesada; Laura Conde; Neus Villamor; Gonzalo R Ordóñez; Pedro Jares; Laia Bassaganyas; Andrew J Ramsay; Sílvia Beà; Magda Pinyol; Alejandra Martínez-Trillos; Mónica López-Guerra; Dolors Colomer; Alba Navarro; Tycho Baumann; Marta Aymerich; María Rozman; Julio Delgado; Eva Giné; Jesús M Hernández; Marcos González-Díaz; Diana A Puente; Gloria Velasco; José M P Freije; José M C Tubío; Romina Royo; Josep L Gelpí; Modesto Orozco; David G Pisano; Jorge Zamora; Miguel Vázquez; Alfonso Valencia; Heinz Himmelbauer; Mónica Bayés; Simon Heath; Marta Gut; Ivo Gut; Xavier Estivill; Armando López-Guillermo; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

4.  FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.

Authors:  F Sellebjerg; M Krakauer; M Khademi; T Olsson; P S Sørensen
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

5.  Immune Regulatory 1 Cells: A Novel and Potent Subset of Human T Regulatory Cells.

Authors:  Nicolas Krause; Jörg Mengwasser; Elpida Phithak; Francisca Beato; Marc Appis; Edgar Louis Milford; Johan Pratschke; Igor Sauer; Anja Kuehl; Arndt Vogel; Michael Goodyear; Linda Hammerich; Frank Tacke; Johanna Faith Haas; Tobias Müller; Nalan Utku
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

Review 6.  CTLA-4 trafficking and surface expression.

Authors:  Elke Valk; Christopher E Rudd; Helga Schneider
Journal:  Trends Immunol       Date:  2008-05-09       Impact factor: 16.687

7.  HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivo.

Authors:  Grit-Carsta Bulwin; Stephanie Wälter; Mirko Schlawinsky; Thomas Heinemann; Anke Schulze; Wolfgang Höhne; Gerd Krause; Wiltrud Kalka-Moll; Patricia Fraser; Hans-Dieter Volk; Jürgen Löhler; Edgar L Milford; Nalân Utku
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

8.  The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma.

Authors:  Thomas Albrecht; Benjamin Goeppert; Fritz Brinkmann; Alphonse Charbel; Qiangnu Zhang; Johannes Schreck; Nina Wilhelm; Stephan Singer; Bruno C Köhler; Christoph Springfeld; Arianeb Mehrabi; Peter Schirmacher; Anja A Kühl; Monika N Vogel; Holger Jansen; Nalân Utku; Stephanie Roessler
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.